1793.5000 -13.70 (-0.76%)
NSE Dec 12, 2025 15:31 PM
Volume: 1.4M
 

1793.50
-0.76%
Motilal Oswal
Sun Pharma (SUNP) delivered in-line revenue/EBITDA in 2QFY26. Earnings came in below our estimates largely due to lower other income.
Sun Pharmaceutical I.. has an average target of 1921.38 from 8 brokers.
More from Sun Pharmaceutical Industries Ltd.
Recommended